Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis
Allotey J, Coomar D, Ensor J, et al.
BMJ. Pub. online 6 Jan 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Long-term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: a 42-month follow-up of the J-MIND-Diabetes study
Sugimoto T, Omura T, Araki A, et al.
Diabetes Obes Metab. Pub. online 8 Jan 2026.
Leggi
The results of ProHCL: patient-reported outcomes in people living with type 1 diabetes on hybrid closed-loop insulin pump therapy – experiences from the NHS England pilot
Griffin TP, Hagan J, Chauhan R, et al.
Diabetes Res Clin Pract. Pub. online 6 Jan 2026.
Leggi
Can the Diabetes Eating Problem Survey-Revised (DEPS-R) reliably identify eating disorder diagnosis in women with type 1 diabetes?
Haugvik S, Hennekes MHCL, de Wit M, et al.
Diabet Med. Pub. online 8 Jan 2026.
Leggi
Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
Kishimori T, Kato T, Iwasaki Y, et al.
Diabetes Obes Metab. Pub. online 5 Jan 2026.
Leggi
Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Zawadka M, Taguiam E, Lê ML, et al.
Diabetes Obes Metab. Pub. online 8 Jan 2026.
Leggi
Effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists on diabetic foot disease : an emulated target trial
Kristensen FPB, Christensen DH, Callaghan BC, et al.
Ann Intern Med. Pub. online 6 Jan 2026.
Leggi
Digital twin paradigm in diabetes prediction and management
Olawade DB, Owhonda RC, Alabi JO, et al.
Diabetes Res Clin Pract. Pub. online 29 Dec 2025.
Leggi
Effect of digital interventions on adherence to the management of type 1 diabetes mellitus patients: a systematic review
Jawad M, Afaq S, Hussain S, et al.
BMC Endocr Disord. Pub. online 30 Dec 2025.
Leggi
GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and immune-related adverse events across cancer types in people with type 2 diabetes: a target-trial emulation
Chan SH, Li PY, Li PH, et al.
Diabetes Res Clin Pract. 2025:113073.
Leggi